|
1
|
Noack M and Miossec P: Selected cytokine
pathways in rheumatoid arthritis. Semin Immunopathol. 39:365–383.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Poledne R and Lesná IK: Inflammation and
atherosclerosis. Vnitr Lek. 64:1142–1146. 2019.PubMed/NCBI
|
|
3
|
Diakos IC, Charles KA, McMillan DC and
Clarke SJ: Cancer-related inflammation and treatment effectiveness.
Lancet Oncol. 15:e493–e503. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lemmers RFH, van Hoek M, Lieverse AG,
Verhoeven AJM, Sijbrands EJG and Mulder MT: The anti-inflammatory
function of high-density lipoprotein in type II diabetes: A
systematic review. J Clin Lipidol. 11:712–724.e5. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Williamson G and Manach C: Bioavailability
and bioefficacy of polyphenols in humans. II. Review of 93
intervention studies. Am J Clin Nutr. 81 (Suppl 1):243S–255S.
2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mennen LI, Walker R, Bennetau-Pelissero C
and Scalbert A: Risks and safety of polyphenol consumption. Am J
Clin Nutr. 81 (1 Suppl):326S–329S. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Woodman OL and Chan EC: Vascular and
anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol
Physiol. 31:786–790. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lu S, Zhou S, Chen J, Zheng J, Ren J, Qi
P, Zhu Z and Li Z: Quercetin nanoparticle ameliorates
lipopolysaccharide-triggered renal inflammatory impairment by
regulation of Sirt1/NF-κB pathway. J Biomed Nanotechnol.
17:230–241. 2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li CY, Cheng SE, Wang SH, Wu JY, Hsieh CW,
Tsou HK and Tsai MS: The anti-inflammatory effects of the bioactive
compounds isolated from alpinia officinarum hance mediated by the
suppression of NF-κB and MAPK signaling. Chin J Physiol. 64:32–42.
2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Berger SI and Iyengar R: Network analyses
in systems pharmacology. Bioinformatics. 25:2466–2472.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shen P, Lin W, Ba X, Huang Y, Chen Z, Han
L, Qin K, Huang Y and Tu S: Quercetin-mediated SIRT1 activation
attenuates collagen-induced mice arthritis. J Ethnopharmacol.
279(114213)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Peng X, Dai C, Zhang M and Das Gupta S:
Molecular mechanisms underlying protective role of quercetin on
copper sulfate-induced nephrotoxicity in mice. Front Vet Sci.
7(586033)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hsin K, Ghosh S and Kitano H: Combining
machine learning systems and multiple docking simulation packages
to improve docking prediction reliability for network pharmacology.
PLoS One. 8(e83922)2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Seshadri VD: Brucine promotes apoptosis in
cervical cancer cells (ME-180) via suppression of inflammation and
cell proliferation by regulating PI3K/AKT/mTOR signaling pathway.
Environ Toxicol. 36:1841–1847. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim MJ, Kim DH, Bang E, Noh SG, Chun P,
Yokozawa T, Moon HR and Chung HY: PPARα Agonist, MHY3200,
alleviates renal inflammation during aging via regulating
ROS/Akt/FoxO1 signaling. Molecules. 26(3197)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gao HN, Hu H, Wen PC, Lian S, Xie XL, Song
HL, Yang ZN and Ren FZ: Yak milk-derived exosomes alleviate
lipopolysaccharide-induced intestinal inflammation by inhibiting
PI3K/AKT/C3 pathway activation. J Dairy Sci. 104:8411–8424.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gulati N, Laudet B, Zohrabian VM, Murali R
and Jhanwar-Uniyal M: The antiproliferative effect of quercetin in
cancer cells is mediated via inhibition of the PI3K-Akt/PKB
pathway. Anticancer Res. 26:1177–1181. 2006.PubMed/NCBI
|
|
19
|
Bellacosa A, Kumar CC, Di Cristofano A and
Testa JR: Activation of AKT kinases in cancer: Implications for
therapeutic targeting. Adv Cancer Res. 94:29–86. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014.PubMed/NCBI View Article : Google Scholar
|
